Generic Name: isotretinoin
Common side effects of Myorisan include: cheilitis, epistaxis, hypertriglyceridemia, pruritus, xerosis, decreased hdl cholesterol, increased liver enzymes, increased serum triglycerides, musculoskeletal signs and symptoms, dry nose, xeroderma, and xerostomia. Other side effects include: increased serum cholesterol.  See below for a comprehensive list of adverse effects.
Applies to isotretinoin: oral capsule, oral capsule liquid filled
In addition to its needed effects, some unwanted effects may be caused by isotretinoin (the active ingredient contained in Myorisan). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking isotretinoin:
Some of the side effects that can occur with isotretinoin may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to isotretinoin: compounding powder, oral capsule
The most commonly reported side effects include dryness of the skin and mucous membranes (e.g., cheilitis, epistaxis, conjunctivitis).[Ref]
Very common (10% or more): Cheilitis/dry lips (up to 90%)Very rare (less than 0.01%): Colitis, ileitis, gastrointestinal hemorrhage, nausea, pancreatitis/fatal pancreatitis, hemorrhagic diarrhea and inflammatory bowel diseaseFrequency not reported: Esophagitis/esophageal ulceration, chapped lips, constipation, diarrhea/severe diarrhea, abdominal pain, vomiting, other nonspecific gastrointestinal symptoms, bleeding and inflammation of the gums[Ref]
Very common (10% or more): Increased red blood cell sedimentation rate (up to 40%)Common (1% to 10%): Neutropenia/severe neutropenia, anemia, thrombocytopenia/decreased platelet counts, thrombocytosisRare (0.01% to 0.1%): AgranulocytosisVery rare (less than 0.01%): LymphadenopathyFrequency not reported: Decreased red blood cell parameters, decreased red blood cell counts/hematocrit, decreased white blood cell counts, increased platelet counts[Ref]
Very common (10% or more): Increased blood triglycerides/hypertriglyceridemia (up to 30%)Common (1% to 10%): Increased blood cholesterol/hyperlipidemia, increased blood glucose/alterations in blood sugar levels, decreased high density lipoproteinVery rare (less than 0.01%): Diabetes mellitus, hyperuricemiaFrequency not reported: Weight loss/fluctuations in weight, decreased appetite, increased low density lipoproteinPostmarketing reports: Increased fasting blood glucose levels[Ref]
Bronchospasm occurred in patients receiving treatment, especially in those with asthma.[Ref]
Very common (10% or more): Epistaxis (Up to 30%)Common (1% to 10%): Hoarseness, nasal dryness, nasopharyngitisVery rare (less than 0.01%): Bronchospasm, dry throatFrequency not reported: Respiratory infection/upper respiratory tract infection, voice alteration[Ref]
In some cases, acne flares occurred during the initial stages of treatment and persisted for several weeks[Ref]
Common (1% to 10%): Dermatitis, dry skin, localized exfoliation, pruritus, rash erythematous, skin fragility/risk of frictional traumaRare (0.01% to 0.1%): Allergic skin reaction, alopecia/persistent or resistant alopeciaVery rare (less than 0.01%): Mucocutaneous/gram positive bacterial infection, allergic vasculitis, acne fulminans, acne aggravated/acne flare, facial erythema, exanthema, hair disorders/persistent hair thinning, hirsutism, nail dystrophy, paronychia, photosensitivity/photoallergic reaction, pyogenic granuloma, skin hyperpigmentation, sweating/increased sweating, increased formation of granulation tissueFrequency not reported: Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, eruptive xanthoma, hypopigmentation, increased sunburn susceptibility, urticaria, eczema, contact dermatitis, sunburn, peeling of the palms and solesPostmarketing reports: Bruising, seborrhea[Ref]
Papilledema occurred as a sign of benign intracranial hypertension.[Ref]
Common (1% to 10%): Blepharitis, conjunctivitis, dry eye, eye irritationVery rare (less than 0.01%): Blurred vision, cataract/lenticular cataracts, color blindness/color vision deficiencies, contact lens intolerance, corneal opacity/reversible corneal opacities, decreased night vision/persistently decreased night vision, keratitis, papilledema, photophobia, visual disturbances, optic neuritis, hordeolumFrequency not reported: Eyelid inflammation, decreased visual acuity, eye pruritus, asthenopia, ocular hyperemia, increased lacrimation[Ref]
Common (1% to 10%): Arthralgia/severe arthralgia, back pain/severe back pain, myalgia/severe myalgia with or without elevated creatine phosphokinase (CPK) levelsVery rare (less than 0.01%): Arthritis, premature epiphyses fusion, exostosis, skeletal hyperostosis/hyperostosis, reduced bone density/decreased bone mineral density, tendonitis, rhabdomyolysis, increased blood CPK, rhabdomyolysis, other types of bone abnormalities, calcinosis/calcification of ligaments and tendonsFrequency not reported: Neck pain, musculoskeletal pain/discomfort/stiffness, extremity pain[Ref]
Back pain occurred more frequently in children and adolescent patients.Rhabdomyolysis, sometimes leading to hospitalization or death, has occurred, especially in patients undertaking vigorous physical activity.[Ref]
Common (1% to 10%): Proteinuria, microscopic or gross hematuriaFrequency not reported: Abnormal menses, nonspecific urogenital findings, white cells in the urine[Ref]
Common (1% to 10%): HeadacheVery rare (less than 0.01%): Benign intracranial hypertension, convulsions, drowsiness, dizzinessFrequency not reported: Stroke, pseudotumor cerebri/increased intracranial pressure, lethargy, paresthesia, seizures, syncope[Ref]
Common (1% to 10%): Transient and reversible increased transaminase levelsVery rare (less than 0.01%): HepatitisFrequency not reported: Increased alkaline phosphatase/lactate dehydrogenase/blood bilirubin[Ref]
Depression symptoms have been reported to disappear after discontinuation of the drug and reappear when treatment is resumed.[Ref]
Rare (0.01% to 0.1%): Depression, aggravated depression, aggression/aggressive tendencies, anxiety, mood alterationsVery rare (less than 0.01%): Abnormal behavior, psychosis/psychotic disorder, suicidal ideation/attempt, suicideFrequency not reported: Nervousness, insomnia, violent behavior, emotional instability, irritability, panic attack, anger, euphoria, behavioral disordersPostmarketing reports: Auditory hallucinations[Ref]
Rare (0.01% to 0.1%): Anaphylactic reaction, hypersensitivity/systemic hypersensitivityFrequency not reported: Allergic reactions[Ref]
Very rare (less than 0.01%): Impaired hearing/impaired hearing at certain frequencies, malaiseFrequency not reported: Fatigue, pain, tinnitus, weakness, disseminated herpes simplex, delayed wound healing, exuberant granulation tissue with crusting, local or systemic infections due to gram positive bacteria (Staphylococcus aureus)Postmarketing reports: Infection[Ref]
Very rare (less than 0.01%): Vasculitis, Wegener's granulomatosisFrequency not reported: Edema, palpitations, tachycardia, vascular thrombotic disease, transient chest pain, flushing[Ref]
Very rare (less than 0.01%): Glomerulonephritis[Ref]
1. Cerner Multum,  Inc. "Australian Product Information." O 0
2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
3. "Product Information. Accutane (isotretinoin)." Roche Laboratories, Nutley, NJ. 
Not all side effects for Myorisan may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Bone or joint pain
burning, redness, itching, or other signs of eye inflammation
difficulty with moving
nosebleeds
scaling, redness, burning, pain, or other signs of inflammation of the lips
skin infection or rash


Abdominal or stomach pain (severe)
attempts at suicide or thoughts of suicide (usually stops after medicine is stopped)
back pain
bleeding or inflammation of the gums
blurred vision or other changes in vision
changes in behavior
decreased vision after sunset or before sunrise (sudden or may continue after medicine is stopped)
diarrhea (severe)
headache (severe or continuing)
mental depression
nausea and vomiting
pain or tenderness of the eyes
pain, tenderness, or stiffness in the muscles (long-term treatment)
rectal bleeding
yellow eyes or skin


Black, tarry stools
bloating
bloody cough
bloody or cloudy urine
bone pain, tenderness, or aching
burning or stinging of the skin
chest pain
confusion
constipation
convulsions
cough or hoarseness
dark-colored urine
decrease in height
difficulty breathing
difficulty speaking
difficulty swallowing
discharge from the eyes
dizziness
double vision
ear pain
excessive tearing
fainting
fast, irregular, pounding, or racing heartbeat or pulse
fever with or without chills
fractures and/or delayed healing
heartburn
high blood pressure
hives or skin rash
inability to move the arms, legs, or facial muscles
inability to speak
indigestion
inflamed tissue from infection
irregular yellow patch or lump on the skin
irritation
joint pain, redness, stiffness, or swelling
lack or slowing of normal growth in children
loosening of the fingernails
loss of appetite
loss of bladder control
loss or change in hearing
muscle cramps, spasms, or weakness
pain in the ribs, arms, or legs
pain or burning in the throat
pain or tenderness around the eyes and cheekbones
painful cold sores or blisters on the lips, nose, eyes, or genitals
painful or difficult urination
pains in the chest, groin, or legs, especially calves of the legs
pains in the stomach, side, or abdomen, possibly radiating to the back
pale skin
pinpoint red spots on the skin
redness or soreness around the fingernails
redness, soreness, or itching skin
sensitivity of the eyes to sunlight
sneezing
sores, ulcers, or white spots on the lips or tongue or inside the mouth
stuffy or runny nose
sudden loss of consciousness
sudden loss of coordination
sudden onset of severe acne on the chest and trunk
sudden onset of slurred speech
swelling of the eyelids, face, lips, hands, lower legs, or feet
swollen, painful or tender lymph glands in the neck, armpit, or groin
tightness in the chest
unusual bleeding or bruising
unusual weight gain or loss
use of extreme physical or emotional force
watery or bloody diarrhea


Crusting of the skin
difficulty in wearing contact lenses (may continue after medicine is stopped)
dryness of the eyes (may continue after treatment is stopped)
dryness of the mouth or nose
dryness or itching of the skin
headache (mild)
increased sensitivity of the skin to sunlight
peeling of the skin on palms of the hands or soles of the feet
stomach upset
thinning of the hair (may continue after treatment is stopped)


Abnormal menstruation
burning, crawling, itching, numbness, prickling, “pins and needles”, or tingling feeling
changes in fingernails or toenails
continuing ringing or buzzing, or other unexplained noise in the ears
dandruff
darkening of the skin
flushing
hair abnormalities
hair loss
increased hair growth, especially on the face
lightening of normal skin color
lightening of treated areas of dark skin
nervousness
oily skin
redness of the face
severe sunburn
skin rash, encrusted, scaly and oozing
stomach burning
sweating
trouble sleeping
unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness
unusually warm skin of the face
voice changes

